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The accumulation of specific peptides or proteins as mis-folded extracellular amyloid fibrils or structurally related intra cellular inclusions is the hallmark of over 40 human 
patho logies, ranging from neurodegenerative disorders (such as, 
Alzheimer’s, Parkinson’s and prion diseases) to non-neuropathic 
systemic amyloidoses (for example, dialysis-related amyloidosis 
and light chain amyloidosis) and localized amyloidoses (such as 
type II diabetes and atrial amyloidosis)1. It is increasingly evident 
that, at least in some protein deposition diseases, the pathogenic 
species are the oligomeric assemblies that precede the formation 
of mature amyloid fibrils2–8. A structural characterization of the 
oligo mers directed to an understanding of the relationship between 
their structural characteristics and their toxic effects is difficult to 
achieve, mainly because these species are typically transient and 
structurally heterogeneous, thus considerably hampering their 
investigation. As a consequence, the structural determinants of the 
protein oligomers that are responsible for cell dysfunction are not 
yet clear.
The small, 91-residue N-terminal domain of Escherichia coli 
HypF (HypF-N) is a stably folded α/β protein with a ferredoxin- 
like fold9. HypF-N is a valuable model system for investigating 
the structural basis of the cellular dysfunction caused by misfolded 
protein oligomers. First, monomeric HypF-N is readily able to form 
spherical oligomers, protofibrils and amyloid-like fibrils in vitro, 
under conditions that destabilize its native state or promote its co- 
operative unfolding into partially structured species10–12. Second, the 
oligomers that form in the early stages of the aggregation process 
have the same morphological, structural and tinctorial features as 
those formed by disease-related peptides and proteins11,12, and they 
impair cell viability when added to the extracellular medium of cul-
tured cells13,14 and when injected into rat brains15. Finally, and most 
importantly in the context of the present study, HypF-N can rap-
idly be converted into oligomers that remain populated persistently, 
rather than transiently, and are sufficiently stable to maintain their 
structure and properties even when transferred to conditions that 
are very different from those that promote their formation.
In this paper we report the finding that two types of stable oligo-
mers can be formed in vitro from HypF-N that are apparently indis-
tinguishable on the basis of thioflavin T (ThT) binding and display 
very similar morphologies when inspected by atomic force micros-
copy (AFM), but that differ in that one induces cellular dysfunction 
whereas the other is benign. This observation not only demon-
strates that aggregates with similar morphology can have different 
biological properties, but also provides a unique opportunity to 
investigate the structural determinants of oligomer toxicity through 
 comparative studies of their properties. By using protein engineer-
ing and structural mapping by means of N-(1-pyrene)maleimide 
(PM) labeling and detection of excimer formation, we have identi-
fied the specific regions of the sequence that are structured in the 
toxic and nontoxic oligomers, determined the major differences 
between them, and addressed the relationship between oligomer 
structure and cellular impairment.
RESULTS
Morphologically similar oligomers show different toxicity
In order to obtain two types of stable oligomeric species, we incu-
bated HypF-N for 4 h at 48 µM, 25 °C in (i) 50 mM acetate buffer, 
12% (v/v) trifluoroethanol (TFE), 2 mM DTT, pH 5.5 (condition A) 
and (ii) 20 mM trifluoroacetic acid (TFA), 330 mM NaCl, pH 1.7 
(condition B). The oligomers were then resuspended in a physio-
logical medium at pH 7.0 with no added co-solvent. Tapping-mode 
AFM (TM-AFM) images revealed the presence of spherical bead-
like aggregates with heights in the range of 2–6 nm and 2–7 nm 
under conditions A (Fig. 1a) and B (Fig. 1b), respectively. ThT 
binding assays showed that both types of oligomers bind this 
amyloid-specific dye and increase its fluorescence to similar 
extents, indicating the presence of extensive intermolecular β-sheet 
 structure (Supplementary Results and Supplementary Fig. 1). 
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The aberrant assembly of peptides and proteins into fibrillar aggregates proceeds through oligomeric intermediates that are 
thought to be the primary pathogenic species in many protein deposition diseases. We describe two types of oligomers formed 
by the HypF-N protein that are morphologically and tinctorially similar, as detected with atomic force microscopy and thioflavin 
T assays, though one is benign when added to cell cultures whereas the other is toxic. Structural investigation at a residue- 
specific level using site-directed labeling with pyrene indicated differences in the packing of the hydrophobic interactions 
between adjacent protein molecules in the oligomers. The lower degree of hydrophobic packing was found to correlate with a 
higher ability to penetrate the cell membrane and cause an influx of Ca2+ ions. Our findings suggest that structural flexibility 
and hydrophobic exposure are primary determinants of the ability of oligomeric assemblies to cause cellular dysfunction and 
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These species did not resolubilize when placed under physiological 
conditions, as indicated by the preservation of their ability to bind 
ThT (Supplementary Fig. 1). Moreover, neither type of oligomer 
underwent any detectable structural reorganization following such 
a change of the medium (see below).
To assess the biological activity of the spherical aggregates 
formed under conditions A and B, we transferred the aggregates to 
physiological conditions and added them to the cell culture media 
of human neuroblastoma cells (SH-SY5Y) and mouse endothelial 
cells (Hend). The state of the cells was first monitored, in each case, 
by performing the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) reduction inhibition assay—a generic bio-
chemical test used to monitor cell viability16. The aggregates formed 
under condition A were found to decrease MTT reduction substan-
tially, relative to untreated cells, in both cell lines (Fig. 1c). Indeed, 
their effect is comparable to that of the oligomers formed by Aβ42 
and IAPP (associated with Alzheimer’s disease and type II diabetes, 
respectively), which were used here as positive controls17,18. By con-
trast, the aggregates formed under condition B had essentially no 
effect on the ability of either SH-SY5Y or Hend cells to reduce MTT 
(Fig. 1c). No inhibition of MTT reduction was observed when the 
cells were treated with native HypF-N (Fig. 1c).
We also stained SH-SY5Y cells with the apoptotic marker Hoechst 
33342, which binds to the highly condensed  chromatin present in 
the nuclei of apoptotic cells, giving rise to a strong  fluorescence 
signal and allowing the visualization of abnormal nuclei18,19. 
Fluorescence microscopy images indicate that the nuclei of the cells 
treated with HypF-N aggregates formed under condition A were 
prominently stained with this dye and often appeared abnormal in 
shape (Fig. 1d), to an extent similar to that of the cells treated with 
Aβ42 and IAPP aggregates (Fig. 1d). By contrast, the nuclei of cells 
treated with the aggregates formed under condition B or with the 
native protein exhibited a much lower degree of staining, similar 
to that of untreated cells (Fig. 1d). Control experiments indicated 
that the lack of toxicity of the species formed under condition B is 
not due to an insufficient quantity of oligomeric aggregates present 
in the experiments (Supplementary Fig. 2). Taken together, these 
results indicate that the same polypeptide sequence can assemble 
into two distinct types of stable oligomers having similar morpho-
logical and tinctorial properties, but different abilities to cause 
cellular dysfunction.
Structural core of the nontoxic HypF-N oligomers
To gain insight into the structural differences of the two types of 
oligomers, we expressed 18 mutational variants of the protein, each 
carrying a single cysteine residue but located at different positions 
along the polypeptide chain, and labeled them with PM. Each 
labeled variant was then allowed to aggregate separately under the 
different conditions, and the fluorescence spectra of the resulting 
samples were acquired and analyzed. PM is a probe of the proxim-
ity between pairs of labeled residues in the species under investiga-
tion, because of its ability to form excited-state dimers, or excimers, 
when two PM moieties are within a short distance (about 10 Å) 
of each other20–22. Excimer formation gives rise to a band in the 
430–470 nm region of the PM fluorescence emission spectrum20–22; 
the presence or absence of this band therefore allows us to deter-
mine whether a labeled position is close (≤10 Å) or distant (>10 Å), 
respectively, to the same labeled position in an adjacent protein 
molecule in the oligomer21,22. One caveat is that the PM moieties 
have the potential to perturb the aggregation process; this potential 
problem is, however, avoided in our comparative experiments, as 
discussed below.
The fluorescence emission spectra of samples containing 































































Figure 1 | Morphology and toxicity of HypF-N aggregates. (a,b) tM-AFM images (left, height data; right, amplitude data) of HypF-n samples  
pre-incubated under conditions A (a) and b (b) and then resuspended at pH 7.0. Scan size, 500 nm. the color bar corresponds to a Z range of 7 nm.  
(c) Mtt reduction assay on SH-SY5Y (gray) and Hend (black) cells untreated (lane 1) or treated with Aβ42 oligomers (lane 2), iApp oligomers (lane 3),  
HypF-n aggregates formed under condition A (lane 4) and b (lane 5), and native HypF-n (lane 6). error bars correspond to the s.d. values of four 
independent experiments. double and triple asterisks refer to P values lower than 0.01 and 0.001, respectively. (d) Hoechst staining of SH-SY5Y cells 
untreated (image 1) or treated with Aβ42 oligomers (image 2), iApp oligomers (image 3), HypF-n aggregates formed under condition A (image 4) and  
b (image 5) and native HypF-n (image 6). the protein concentration reported refers to monomer concentrations. All images have been acquired at the 
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under condition B did not feature an excimer component in the 
430–470 nm region (Fig. 2a–f). In all other cases an excimer peak 
centered at about 440 nm was detected in the fluorescence spec-
trum; this peak was, however, of low intensity for protein variants 
labeled at residues 22, 28, 34, 40, 65, 69, 75 and 89, but of higher 
intensity when residues 25, 55, 59, 79, 83 and 87 were labeled 
(Fig. 2a–f). These results indicate that for the first group of variants, 
those exhibiting no excimer band, the distance between the labeled 
residues in adjacent molecules is greater than 10 Å. For the second 
group of variants, with weak excimer bands, the labeled residues 
are at intermediate distances from each other in the oligomers, or 
alternatively in close proximity in only a fraction of the oligomers 
that are present in solution. Finally, for the third group of variants, 
those with strong excimer bands, the labeled residues are in close 
proximity (≤ 10 Å) to the same residue on one or more adjacent 
molecules and indeed are likely to adopt well-defined structure.
From such data we were able to calculate the ratio of the excimer- 
to-monomer fluorescence intensities (FI440nm/FI375nm) for each 
labeled residue (Fig. 2g). The profile of excimer ratio versus residue 
number suggests that the regions spanning approximately residues 
22–34, 55–59 and 75–87 form the structural core of the HypF-N 
oligo mers formed under condition B, as the residues in these regions 
of the sequence have a high tendency to be in close proximity with 
the corresponding residues of adjacent molecules within the 
oligomers. The excimer ratio data do not rule out the possibility 
that the residues within these regions are also in close proximity 
with residues located in other portions of the protein chain (see 
below). Nevertheless, they clearly indicate that specific regions of 
the  molecule are tightly packed within the structural core of these 
HypF-N oligomers. Notably, there is excellent agreement between 
the locations of these three regions (Fig. 2g) and the three major 
peaks in the hydropathy profile of HypF-N (Fig. 2h); our data 
 indicate, therefore, that the regions of the sequence with the  highest 
hydrophobicity contribute to the structural core of the nontoxic 
aggregates formed by HypF-N.
The core of the toxic oligomers is less tightly packed
The same approach was then used to gain insight into the structure 
of the toxic aggregates formed under condition A (Fig. 3a–f). For 
these species, molecules labeled at residues 5, 10, 34, 40, 47 and 89 
had no significant excimer components in the spectra (Fig. 3a,c,f). 
By contrast, all the remaining positions (18, 22, 25, 28, 55, 59, 65, 69, 
75, 79, 83 and 87) showed faint excimer peaks (Fig. 3a–f). None of 
the labeled variants gave rise to spectra with intense excimer bands 
(Fig. 3a–f), indicating that in no case do adjacent molecules pack 
together such that their corresponding residues are persistently in 
close proximity. A comparison between the values of the excimer 
ratios obtained for the toxic and nontoxic aggregates is reported 
in Figure 3g. The major differences involve the three hydrophobic 
regions of the sequence that yield high values of excimer ratio in 
the nontoxic aggregates and much smaller values in the toxic ones 
(Fig. 3g). Differences between the values of excimer ratio in the other 
regions are either insignificant or, at most, subtle (Fig. 3g). This 
finding indicates that the degree of ordered intermolecular packing 
between corresponding hydrophobic regions of adjacent HypF-N 



























































































Figure 2 | Structural properties of the oligomers formed under condition b. (a–f) Fluorescence emission spectra of HypF-n oligomers formed under 
condition b by protein chains labeled with pM at different positions. Spectra were acquired at 48 µM protein. the color code reported in each panel helps 
associate the spectrum with the position of pM labeling. Spectra have been normalized to the intensity of the peak centered at 375 nm. (g) Ratio between 
the fluorescence intensities measured at 440 nm (excimer peak) and 375 nm (monomer peak) for all the labeled positions along the HypF-n sequence. 
error bars correspond to s.d. of at least two independent experiments per position. (h) Hydropathy profile of HypF-n calculated using the Roseman 
hydrophobicity scale44. the positions of α-helices (red) and β-strands (blue) in the native structure (protein data bank entry 1GXu) are also indicated  
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We also recorded the fluorescence emission spectra of 1:1  mixtures 
of aggregates labeled with PM at different positions (25, 55, 59, 
83, 87), prepared under both conditions A and B (Supplementary 
Fig. 3a,b). At least in some cases, distinct positions from adjacent 
molecules appeared to be spatially close as they gave rise to a medium 
or strong excimer signal. However, the excimer ratio values obtained 
for the toxic oligomers were considerably lower than those of the 
nontoxic oligomers.
To obtain information on the polarity of the environment explored 
by the PM moieties in the oligomers formed under  conditions A and B, 
we calculated the ratio of the fluorescence intensities at 375 nm 
(II) and 385 nm (IIII) for all the labeled positions along the HypF-N 
sequence23. A value of 2.78 was obtained for the II/IIII ratio for a 
fully soluble and unstructured PM-labeled glutathione dissolved in 
water (Supplementary Fig. 4). This value is in agreement with that 
reported elsewhere for a fully solvent-exposed PM conjugated to 
proteins24–26 and represents an upper bound for our measurements. 
The II/IIII values obtained for the two types of HypF-N aggregates 
indicate that the PM moieties are more accessible to the solvent 
(higher II/IIII ratios) in the toxic oligomers formed under condition 
A than in the nontoxic oligomers formed under condition B, parti-
cularly at the level of the three major hydrophobic regions (Fig. 3h). 
Moreover, in the case of the oligomers formed under condition B, 
there is a good agreement between the labeled positions found 
to be buried into a nonpolar environment and the regions of the 
sequence that form the structural core of the aggregates—that is, 
22–34, 55–59 and 75–87 (Fig. 3g,h). Overall, the results of the 
excimer and II/IIII ratio values indicate that in the toxic oligomers, 
the hydrophobic regions are structurally more highly disorganized 
and solvent-exposed than they are in the nontoxic oligomers.
The structural differences do not arise from artifacts
In order to interpret the data reported here, it is important to address 
the possibility that the PM moieties perturb in some manner the aggre-
gation behavior of HypF-N in one or both of the conditions in which 
these studies were carried out. TM-AFM images obtained for HypF-N 
samples labeled at positions 10 and 59 and left to aggregate under con-
ditions A and B showed that the globular morphology of the aggre-
gates is preserved upon labeling (Supplementary Fig. 5). Moreover, 
both types of HypF-N oligomers labeled at positions 10, 25, 47 and 59 
retained the ability to bind ThT (Supplementary Fig. 6a).
In more structural detail, our analysis is comparative and aims 
to explore any significant structural differences between the two 

















































































































































Figure 3 | Structural properties of the oligomers formed under condition a. (a–f) Fluorescence emission spectra of HypF-n oligomers formed under 
condition A by protein chains labeled with pM at different positions. Spectra were acquired at 48 µM protein. the color code reported in each panel helps 
associate the spectrum with the position of pM labeling. (g) excimer ratio profiles of HypF-n oligomers formed under conditions A (red) and b (blue). 
error bars correspond to s.d. of at least two independent experiments per position. (h) Ratio between the fluorescence intensities measured at 375 nm 
(Ii) and 385 nm (Iiii) for all the labeled positions along the HypF-n sequence. error bars correspond to s.d. of at least two independent experiments. low 
and high ratio values correspond to a nonpolar and highly polar environment, respectively23. values of 2.78 and 2.03 were obtained for glutathione labeled 
with pM and dissolved in water and 1-octanol, respectively (Supplementary Fig. 4). our values are higher than those previously reported for free pyrene23. 
Similar values have also been obtained by other authors24–26 and are due to the fact that pyrene is conjugated to a polypeptide chain through a maleimide 
moiety rather than being free in solution. (i) AnS binding to HypF-n oligomers formed under condition A (red) and b (blue). the AnS fluorescence 
intensity measured at 470 nm (filled circles) and the wavelength of maximum emission (λmax, empty circles) are reported as a function of the AnS 
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ratios measured at given positions for the two types of aggregates 
are unlikely to be the result of an intrinsic ability of the fluoro-
phore to affect the aggregation process, as this interference would 
be revealed in both sets of conditions at the same positions. The 
observation that the excimer ratio is higher for the species formed 
under condition A at only a small number of positions rules out 
the possibility that the ability of PM to perturb the oligomeriza-
tion process is condition-dependent. Moreover, the low values of 
the excimer ratios at some positions indicate that PM does not 
intrinsically drive the formation of intermolecular interactions 
between PM moieties from different HypF-N molecules. As a fur-
ther confirmation, fluorescence emission spectra acquired under 
both conditions with PM-labeled β-mercaptoethanol indicated 
that the PM moiety is intrinsically soluble under the  experimental 
conditions used in the present study and does not per se drive the 
aggregation process (Supplementary Fig. 6b).
In order to check whether the oligomeric species formed in 
conditions A and B varied their structure upon transfer into a 
 physiological buffer at neutral pH, in which the morphology and 
toxicity to cultured cells was assessed, samples of HypF-N labeled 
at positions 10, 25, 47, 59, 65 and 83 were separately incubated 
in both conditions A and B and analyzed before and after dilu-
tion into 20 mM potassium phosphate buffer, pH 7.0. For each 
sample, the resulting PM emission spectra were similar before 
and after change of solution conditions, ruling out the possibil-
ity of marked structural changes within the preformed aggregates 
(Supplementary Fig. 7).
In another control experiment, the effect of protein concentra-
tion on the excimer ratio values was also tested, indicating that 
the difference between toxic and nontoxic aggregates  persists 
at all protein concentrations examined, including the lowest 
(Supplementary Fig. 3c). Finally, oligomers formed in condi-
tion B using 1:1 mixtures of labeled and unlabeled chains did not 
exhibit marked excimer ratio values, indicating that low values 
of the  excimer ratio for the nontoxic oligomers are obtained only 
when the probability of two PM moieties being in close proximity 
is reduced (Supplementary Fig. 3d).
Toxic oligomers bind aNS more tightly
To have an independent probe of hydrophobic exposure in the 
two types of oligomers, we also tested the ability of the two  species 
to interact with 8-anilinonaphthalene-1-sulfonate (ANS), a dye 
that has been shown to bind to solvent-exposed  hydrophobic 
a













Figure 4 | interaction of the aggregates formed under conditions a and b with cells. (a–d) confocal scanning microscopy images of SH-SY5Y cells 
untreated (a) or treated with 12 µM native HypF-n (b), 12 µM HypF-n pre-incubated under condition A (c) and 12 µM HypF-n pre-incubated under 
condition b (d). (e–j) optical sections taken through the cells after treatment with 12 µM HypF-n pre-incubated under conditions A (e–g) and b (h–j)  








Figure 5 | Dysregulation of cytosolic Ca2+ by aggregates formed under 
conditions a and b. (a–d) confocal scanning microscopy images of  
SH-SY5Y cells showing changes in intracellular free ca2+ levels, when cells 
are untreated (a) or treated with 12 µM native HypF-n (b), 12 µM HypF-n 
pre-incubated under condition A (c) and 12 µM HypF-n pre-incubated 
under condition b (d). in all images, the green fluorescence arises from the 
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clusters, and thereby to generate a marked increase in its 
fluorescence emission intensity and a blue shift of its maximum 
emission wavelength27,28. At equivalent ANS concentrations, 
the  fluorescence intensity measured in the presence of the toxic 
 oligomers was higher than that obtained with nontoxic oligomers, 
indicating a higher degree of exposure to the solvent of hydrophobic 
clusters in the toxic species (Fig. 3i). Moreover, the wavelength of 
maximum emission (λmax) was lower for the toxic oligomers than for 
the nontoxic species, indicating that the dye interacts with a more 
nonpolar environment (Fig. 3i). No significant ANS binding was 
detected for native HypF-N (Supplementary Fig. 8).
HypF-N oligomers differ in cell membrane interaction
It has repeatedly been reported that oligomers can interact with and 
permeabilize synthetic lipid vesicles29 and cell membranes14. In order 
to assess whether or not the structural differences between the two 
types of oligomers detected with PM labeling and ANS binding are 
associated with differences in their interactions with the cell mem-
brane, HypF-N aggregates formed under conditions A and B were 
added to SH-SY5Y cell culture media. The cells were then exten-
sively washed and examined by confocal scanning microscopy and 
immunofluorescence using anti-HypF-N antibodies. Both toxic and 
nontoxic oligomers were found to bind to the treated cells; by con-
trast, control experiments carried out with the monomeric protein 
showed no interaction (Fig. 4a–d). Nevertheless, the imaging of dif-
ferent optical sections of the cells exposed to the oligomers, including 
basal, apical and intermediate median planes, revealed the presence 
of HypF-N aggregates inside the cells (median planes) only when 
these were treated with the toxic oligomers formed under condition A 
(Fig. 4e–j). The presence of only toxic oligomers inside the cells cannot 
be attributed to the different size of these species, as AFM images indi-
cate that the two types of oligomers are  submicroscopic and comparable 
in size (Fig. 1a,b). In addition, small green dots were detectable in con-
focal microscopy images outside the cells in both cases (Supplementary 
Fig. 9). These results indicate that only the toxic aggregates have suffi-
ciently high structural plasticity and hydrophobic surface to penetrate 
the cell membrane and even cross it and reach the interior of the cell.
We then performed a confocal microscope analysis of the cyto-
solic Ca2+ content in SH-SY5Y cells upon exposure to HypF-N 
aggregates. Addition of the toxic oligomers formed under condi-
tion A to the cell culture media was found to cause a large influx 
of extracellular Ca2+ ions into the cytosol, much like the oligomers 
formed by other proteins and peptides30; by contrast, addition of the 
nontoxic oligomers formed under condition B did not cause any 
increase of intracellular Ca2+ ions, as observed upon exposure to the 
native protein (Fig. 5).
The ability of both types of oligomers to bind to cell membranes 
is consistent with the observation that both can bind to ANS, albeit 
with different efficiencies. However, the finding that only the toxic 
oligomers cross the hydrophobic bilayer of the cell membrane is 
consistent with the conclusions of the PM-labeling and ANS bind-
ing studies that the hydrophobic regions of the toxic oligomers are 
more structurally disorganized and solvent exposed than those of 
the nontoxic species.
DiSCUSSiON
It is well known that incubation of the same peptide or protein under 
different experimental conditions causes the formation of oligomers 
or fibrils with different morphologies and that such differences 
result in different degrees of toxicity31–35. Similarly, mutations or 
covalent modifications can result in different levels of oligomers or 
different fibrillar structures with completely different toxicities36,37. 
However, little experimental information is available on the struc-
tural features of oligomers grown under different conditions and on 
the relationship between their structure and their ability to cause 
cell dysfunction. In the present study, oligomers formed from the 
same protein under different conditions were found to exhibit 
similar  morphological and tinctorial properties, yet they differ 
in their molecular structure and ability to cause cell dysfunction. 
Comparisons of the two types of aggregates described here indi-
cate that their structural differences result from different degrees 
of packing of the hydrophobic residues within their cores, with 
 toxicity associated with the level of structural flexibility and solvent-
exposure of such residues. Furthermore, our results indicate that the 
toxicity is associated with the ability of the oligomeric species to 
form a more pronounced and disruptive interaction with the cells, 
stimulating Ca2+ influx and leading to cell death. Hence, whereas 
the ability to form amyloid-like structures is generic to polypeptide 
chains, whether or not such species are pathogenic depends on their 
structural features, notably the extent to which hydrophobic resi-
dues are flexible and exposed on their surfaces within the environ-
ment of a living organism.
Our ability to characterize these two forms of oligomers can be 
attributed to the high aggregation propensity of HypF-N, which 
has allowed oligomeric states that would normally be metastable 
to be trapped. Our findings, however, do not seem to be limited 
to the HypF-N aggregates, and could indeed explain the toxic 
properties of the oligomers formed by disease-related systems. 
Hydrogen/deuterium (H/D) exchange measurements carried out 
on the protofibrils and mature fibrils formed by the 40-residue 
form of the amyloid-β peptide (Aβ40), the peptide associated with 
Alzheimer’s disease, indicate that the degree of protection from H/D 
exchange, observed at the level of the two regions of the sequence 
forming the structural core of both types of aggregates, is higher 
in the fibrils than in the protofibrils38. Moreover, in the case of the 
fibrils, some of the residues flanking these two regions are also pro-
tected from H/D exchange38. Notably, these two regions correspond 
to the highest peaks in the hydropathy profile of this peptide, sug-
gesting that the higher degree of structure of these hydrophobic 
portions of the sequence in the fibrils could explain why mature 
Aβ40 fibrils are less toxic than protofibrils6. Other results also indi-
cate a correlation between the size and surface hydrophobicity of 
Aβ40 aggregates and their ability to decrease the bilayer fluidity of 
model membranes39, suggesting that the exposure to the solvent 
of  hydrophobic surfaces determines the ability of these species to 
interact with cell  membranes. A correlation between hydrophobic-
ity, tendency to form aggregates and aggregate cytotoxicity has also 
been observed in comparative studies where the behavior of different 
homopolymeric amino acid (HPAA) stretches was investigated40,41.
It has been recently reported that expanded huntingtin-exon1 
forms fibrillar aggregates at two different temperatures that have 
different structural and physical properties as well as different cyto-
toxicities35. The structures and toxicities of both forms of the aggre-
gates are comparable with those extracted from regions of mouse 
brains affected to different extents by huntingtin deposition. In both 
pairs of structures, a direct relationship between structural flexibil-
ity and cytotoxicity of amyloid assemblies was found, supporting 
the generality of our conclusions35.
In conclusion, the data obtained here lend support to the idea 
that a key feature in the generation of toxicity is the conversion of a 
species of aggregates in which stability is associated with extreme 
burial of hydrophobic residues to one in which such residues are 
substantially exposed and disorganized42. On the same grounds, 
we suggest that for therapeutic purposes the toxicity can be 
substantially reduced if the hydrophobic residues are incorpo-
rated to a greater extent within the interior of the oligomeric 
assemblies, even in the absence of an effective change in mor-
phology. From a broader perspective, our data establish a link 
between bio logical activity of aberrant protein oligomers and 
precise structural features within them. They suggest that 
solvent-exposed and structurally disorganized hydrophobic 
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 pathogenesis of  important debilitating human diseases and can 
 represent  important molecular targets for therapeutic intervention.
METHODS
Protein expression, purification and mutagenesis. Wild-type and mutated 
HypF-N production was carried out as described in Supplementary Methods. 
Purified proteins were stored at −20 °C in 5 mM acetate buffer, pH 5.5, with 2 mM 
dithiothreitol (DTT). Mutations in the gene coding for wild-type HypF-N were 
generated using the QuickChange site-directed mutagenesis kit (Stratagene), as 
described in Supplementary Methods. The molecular mass of the purified vari-
ants was checked with MALDI-MS. The protein purity was found by SDS-PAGE 
to be >95% in all cases. The purified variants were stored at −20 °C in 100 mM 
potassium phosphate buffer, pH 7.0, with 2 mM tris(2-carboxyethyl)phosphine 
hydrochloride.
Preparation of HypF-N oligomers. Oligomers were prepared by diluting the  
protein stock solution to 48 µM in (i) 50 mM acetate buffer, 12% (v/v) trifluoro-
ethanol (TFE), 2 mM DTT, pH 5.5 (condition A) and (ii) 20 mM trifluoroacetic 
acid (TFA), 330 mM NaCl, pH 1.7 (condition B). The resulting samples were  
incubated for 4 h at 25 °C.
TM-AFM. Aggregates were centrifuged at 16,100 r.c.f. for 10 min and resuspended 
in potassium phosphate buffer, pH 7.0. 10 µl of each sample was diluted 100 times 
(or 500 times for samples not resuspended at pH 7.0), deposited on a freshly 
cleaved mica substrate and dried under vacuum. TM-AFM images were acquired 
in air using a Dimension 3100 SPM with a ‘G’ scanning head (maximum scan 
size 100 µm) and driven by a Nanoscope IIIa controller, and a Multimode SPM 
equipped with ‘E’ scanning head (maximum scan size 10 µm) and driven by a 
Nanoscope IV controller (Digital Instruments, Veeco). Single beam uncoated silicon  
cantilevers (type OMCL-AC160TS, Olympus) were used. The drive frequency 
was between 320 and 340 kHz; the scan rate was 0.5–2.0 Hz. Aggregate sizes were 
measured from the height in cross section of the topographic AFM images; due to 
the drying procedure applied, the measured heights were multiplied by a shrinking 
factor of 2.2 and evaluated comparing the heights of native HypF-N under liquid 
and after drying.
MTT assay and Hoeschst staining test. Human SH-SY5Y neuroblastoma cells 
and mouse Hend endothelium cells were cultured as described in Supplementary 
Methods. Both types of HypF-N aggregates were centrifuged at 16,100 r.c.f., dried 
under N2 to remove TFE when necessary, dissolved in DMEM without phenol red 
and immediately added to the cell media of SH-SY5Y and Hend cells for 24 h, at 12 µM  
monomer concentration. Aggregates of Aβ42 and IAPP (refs. 17,18) were tested at 
the same concentration. HypF-N aggregates formed under condition B were also 
tested at 2 and 48 µM. Native HypF-N was tested by diluting the stock solution of 
HypF-N to a final protein concentration of 12 µM. Cytotoxicity was assessed by the 
MTT assay as reported in Supplementary Methods. SH-SY5Y cells treated  
for 24 h with 12 µM of the aggregates formed by HypF-N, Aβ42 and IAPP or  
12 µM native HypF-N were stained with the Hoechst 33342 dye as described in 
Supplementary Methods.
Labeling with PM. Each protein variant was diluted to 0.2 mM in 100 mM  
potassium phosphate, pH 7.0, 3 M guanidine hydrochloride. Aliquots of PM 
(Molecular Probes) in DMSO were added to a tenfold molar excess of dye. The 
sample was left in the dark on a shaker for 1 h at 37 °C, then overnight at 4 °C.  
The reaction was quenched with 5 µl of trifluoroacetic acid. The unbound dye  
was removed by extensive dialysis (3.0 kDa cutoff), and the sample was centrifuged 
to remove any precipitate. The concentration of PM was determined using ε344nm =  
40,000 M–1 cm–1 (ref. 43). Protein concentration was measured at 280 nm after  
subtraction of the contribution of PM.
Pyrene fluorescence emission spectra. Fluorescence emission spectra of the type A 
and B PM-labeled aggregates were measured at 25 °C on a PerkinElmer LS 55  
spectrofluorimeter with an excitation of 344 nm. Protein concentration was 48 µM. 
The spectra were smoothed and normalized to the intensity of the peak at 375 nm.
ANS titration. Both types of HypF-N aggregates formed at 48 µM were centrifuged 
for 10 min at 16,100 r.c.f. The pellets were resuspended in 20 mM potassium phos-
phate buffer, pH 7.0. Aliquots of ANS from a stock solution in 20 mM potassium 
phosphate buffer, pH 7.0, were subsequently added to the aggregates, to a final 
ANS concentration ranging from 0 to 237 µM. The final protein concentration 
was 43 µM in all cases. The spectra were immediately acquired and processed as 
described in Supplementary Methods. The difference between the resulting fluo-
rescence intensity at 470 nm and that measured with only protein in the absence of 
ANS was used as the effective ANS fluorescence.
Interaction of the aggregates with the cell membrane. SH-SY5Y cells were seeded 
on glass coverslips and analyzed using a Leica TCS SP5 confocal scanning micro-
scope, equipped with an argon laser source. Cells were first treated for 60 min at  
37 °C with native HypF-N or with aggregates formed under conditions A and B, 
after centrifugation at 16,100 r.c.f. and resuspension of the pellet in DMEM without 
phenol red. The final protein concentration was 12 µM. The cells were washed with 
phosphate-buffered saline, counterstained for 10 min with 50 µg ml–1 Alexa Fluor 
633–conjugated wheat germ agglutinin and fixed in 2% (w/v) buffered  
paraformaldehyde for 10 min at room temperature (20 °C). After plasma  
membrane permeabilization with a 3% (v/v) glycerol solution for 5 min, the cover-
slips were incubated for 60 min with 1:1,000 diluted rabbit polyclonal anti-HypF-N 
antibodies (Primm srl) and then for 90 min with 1:1,000 diluted Alexa Fluor 
488–conjugated anti-rabbit secondary antibodies.
Cytosolic Ca2+ dysregulation. SH-SY5Y cells seeded on glass coverslips were 
treated with native HypF-N or aggregates as described above. Cells were then 
washed and loaded for 30 min at 37 °C with 10 µM Fluo3-AM, 0.01% (w/v) 
pluronic acid F-127 in Hank’s Balanced Salt Solution. Cells were then washed and 
fixed in 2.0% (w/v) buffered paraformaldehyde for 10 min at room temperature. 
The analysis was performed using the confocal scanning system described above.
Accession codes. Protein Data Bank: The native structure of HypF-N was  
deposited as part of a previous study under accession code 1GXU. 
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